1. Home
  2. ARQT vs DOCS Comparison

ARQT vs DOCS Comparison

Compare ARQT & DOCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$24.14

Market Cap

3.2B

Sector

Health Care

ML Signal

HOLD

Logo Doximity Inc.

DOCS

Doximity Inc.

HOLD

Current Price

$29.12

Market Cap

3.8B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARQT
DOCS
Founded
2016
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.8B
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
ARQT
DOCS
Price
$24.14
$29.12
Analyst Decision
Buy
Hold
Analyst Count
7
21
Target Price
★ $37.00
$29.67
AVG Volume (30 Days)
2.4M
★ 2.6M
Earning Date
10-27-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 88.79
N/A
EPS
0.03
★ 0.13
Revenue
$376,072,000.00
★ $644,863,000.00
Revenue This Year
$42.98
$5.04
Revenue Next Year
$27.75
$6.64
P/E Ratio
$816.33
★ $226.00
Revenue Growth
★ 91.34
13.05
52 Week Low
$19.30
$17.15
52 Week High
$31.77
$71.37

Technical Indicators

Market Signals
Indicator
ARQT
DOCS
Relative Strength Index (RSI) 42.22 66.73
Support Level $22.82 $23.71
Resistance Level $24.67 $40.00
Average True Range (ATR) 1.27 1.09
MACD -0.25 0.16
Stochastic Oscillator 15.55 97.89

Price Performance

Historical Comparison
ARQT
DOCS

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

About DOCS Doximity Inc.

Doximity Inc provides an online platform, which enables physicians and other healthcare professionals to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The Company's customers include pharmaceutical companies and health systems that connect with healthcare professionals through the Company's digital Marketing, Hiring, and Workflow Solutions. Marketing Solutions provide customers with the ability to share tailored content on the network. Hiring Solutions enable customers to identify, connect with, and hire from the network of both active and passive potential medical professional candidates.

Share on Social Networks: